VISTAGEN THERAPEUTICS INC has a total of 57 patent applications. It increased the IP activity by 66.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NANJING NORATE PHARMACEUTICAL TECH CO LTD, UNITED THERAPEUTICS CORP and BIOREX KFT.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 8 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | China | 6 | |
#5 | Australia | 4 | |
#6 | Canada | 4 | |
#7 | Hong Kong | 3 | |
#8 | Israel | 3 | |
#9 | Japan | 3 | |
#10 | South Africa | 3 | |
#11 | Brazil | 2 | |
#12 | Republic of Korea | 2 | |
#13 | Mexico | 2 | |
#14 | Serbia | 1 | |
#15 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Snodgrass H Ralph | 25 |
#2 | Hicklin Jack S | 21 |
#3 | Cato Allen E | 20 |
#4 | Abele Stefan | 8 |
#5 | Laue Klaus | 8 |
#6 | Breitenmoser Roland A | 7 |
#7 | H Ralph Snodgrass | 6 |
#8 | Jack S Hicklin | 6 |
#9 | Allen E Cato | 5 |
#10 | Snodgrass Ralph H | 5 |
Publication | Filing date | Title |
---|---|---|
WO2020210473A1 | Genetic variants associated with response to treatment of neurological disorders | |
WO2019157426A1 | Synthesis of 4-chlorokynurenines and intermediates | |
CN107949379A | The therapeutical uses of 4 chloro kynurenins of L | |
CN105164100A | Methods for the synthesis of chiral kynurenine compounds | |
CN105164096A | Synthesis of chiral kynurenine compounds and intermediates | |
MX2015009277A | Dosage forms and therapeutic uses l-4-chlorokynurenine. | |
WO2011119942A1 | Induction of ips cells using transient episomal vectors | |
EP2297298A2 | Pancreatic endocrine progenitor cells derived from pluripotent stem cells |